Safety problems on Sulpiride and other 4 ingredients surfaced.
Published: 2005-04-28 07:00:00
Updated: 2005-04-28 07:00:00
The KFDA's drug safety review on 5 drugs including Sulpiride, a gastric motility enhancing drug known as 60 billion won of the market being already established, non-steroid anti-inflammatory drugs and atopic dermatological drug will be soon reported.
The safety review results will be soon rep...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
